| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5104896 | Value in Health | 2016 | 12 Pages |
Abstract
Introducing QIV into the US immunization program may prevent a substantial number of hospitalizations and deaths. QIV is also expected to be a cost-effective alternative option to TIV.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Pieter T. MSc, Pascal PhD, Richard J. PhD, Bérengère PharmD, Ayman PhD, Maarten J. PhD,